KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Precigen (PGEN) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Precigen (PGEN) over the last 14 years, with Q3 2025 value amounting to $37.4 million.

  • Precigen's Operating Expenses rose 6836.82% to $37.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $123.7 million, marking a year-over-year decrease of 1453.63%. This contributed to the annual value of $139.0 million for FY2024, which is 3110.97% up from last year.
  • Precigen's Operating Expenses amounted to $37.4 million in Q3 2025, which was up 6836.82% from $32.6 million recorded in Q2 2025.
  • Over the past 5 years, Precigen's Operating Expenses peaked at $61.6 million during Q2 2024, and registered a low of $22.2 million during Q3 2024.
  • Over the past 5 years, Precigen's median Operating Expenses value was $25.6 million (recorded in 2021), while the average stood at $29.7 million.
  • As far as peak fluctuations go, Precigen's Operating Expenses surged by 25058.63% in 2021, and later crashed by 4700.93% in 2025.
  • Over the past 5 years, Precigen's Operating Expenses (Quarter) stood at $25.6 million in 2021, then dropped by 7.81% to $23.6 million in 2022, then soared by 50.48% to $35.5 million in 2023, then decreased by 16.21% to $29.7 million in 2024, then grew by 25.91% to $37.4 million in 2025.
  • Its Operating Expenses stands at $37.4 million for Q3 2025, versus $32.6 million for Q2 2025 and $23.9 million for Q1 2025.